Latest News - West Pharmaceutical
Top Corporates Hub
West Pharmaceutical
DXCM Secures Health Canada Authorization for Dexcom G7 15 Day CGM
14.07.2026 14:20
DexCom's G7 15 Day wins Health Canada authorization, offering longer wear, high accuracy and smart features for adults with diabetes.
Quest Diagnostics to Report Q2 Earnings: Key Customer Channels in Focus
14.07.2026 13:58
DGX's Q2 results may reflect growth across physician, hospital and consumer channels as AI tools and advanced diagnostics gain traction.
Zacks Industry Outlook McKesson, Cardinal, West Pharmaceutical, Align and Henry
14.07.2026 07:31
McKesson, Cardinal, West Pharmaceutical, Align and Henry have been highlighted in this Industry Outlook article.
BNP Paribas Initiates Coverage of West Pharmaceutical Services (WST) with Outperform Recommendation
14.07.2026 01:36
Insulet Broadens Omnipod 5 Presence With Commercial Launch in Spain
08.07.2026 14:21
PODD expands Omnipod 5 to Spain, marking its 20th country launch and adding Omnipod Discover to strengthen digital diabetes care.
West to Host Second-Quarter 2026 Conference Call
07.07.2026 10:00
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release second-quarter 2026 financial results before the market opens on Thursday, July 23, 2026, and will follow with a conference call to discuss the results and business expectations at 8:00 a.m. Eastern Time.
West Pharmaceutical Services (WST) Stock Looks Overvalued Despite Upcoming Q2 Earnings
04.07.2026 08:08
West Pharmaceutical Services has delivered a strong 65.1% return over the past year, yet its valuation checks and current pricing suggest the stock is far from a clear bargain. Over the last 12 months, West Pharmaceutical Services shares are up 65.1%. This puts extra focus on whether recent gains already reflect investors' expectations. Anticipation of ongoing earnings growth and portfolio changes such as the sale of certain SmartDose manufacturing rights can support a higher valuation. Any...
Veeva Acquires Copli & Launches Falcon MLR for Faster Content Reviews
29.06.2026 16:26
VEEV expands its AI push with Copli acquisition and Falcon MLR launch, aiming to speed life sciences content reviews and boost Commercial Cloud.
RDNT's Unit DeepHealth Expands AI Breast Suite With FDA-Cleared Tools
29.06.2026 13:53
RadNet's DeepHealth gains FDA clearances for AI breast imaging tools that assess cardiovascular risk and compare prior mammograms.
AMN Expands Workforce Intelligence Through Brightfield Alliance
25.06.2026 15:39
AMN Healthcare's alliance with Brightfield boosts workforce intelligence, pairing TDX with analytics to support smarter healthcare labor planning.
Here's Why You Should Retain Inogen Stock in Your Portfolio for Now
25.06.2026 14:12
INGN's POC strength, expanding respiratory portfolio and international momentum support growth, though U.S. revenue pressure remains a key risk.
1 High-Flying Stock Worth Your Attention and 2 Facing Challenges
25.06.2026 12:49
“You get what you pay for” often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated volatility during market downturns when expectations change.
MiniMed Launches Abbott's Instinct Sensors Across European Markets
24.06.2026 16:17
MMED expands its European diabetes tech reach with Abbott sensor integration, boosting user flexibility and its connected care ecosystem.
Here's Why You Should Retain Ecolab Stock in Your Portfolio Now
24.06.2026 16:14
ECL's strong Q1 earnings, digital growth and expanding high-tech platform support long-term upside despite rising cost pressures.
1 Cash-Producing Stock with Exciting Potential and 2 We Brush Off
24.06.2026 08:56
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
InspireMD Posts Positive CGUARDIANS II Data for CGuard Prime TCAR
16.06.2026 16:41
NSPR's positive CGUARDIANS II data show 100% acute device success, supporting a potential FDA approval for CGuard Prime TCAR in late 2026.
DXCM Receives FDA Clearance for Stelo OTC CGM System for Children
16.06.2026 13:55
DexCom's FDA-cleared Stelo OTC glucose biosensor now covers children aged above 2 years not using insulin, expanding access to smartphone-linked CGM insights.
Here's Why You Should Retain BDX Stock in Your Portfolio Now
16.06.2026 13:54
Becton, Dickinson's MedTech focus, innovation push and strategic partnerships support growth optimism, though reimbursement uncertainty remains a key concern.
How Investors May Respond To West Pharmaceutical Services (WST) Upgraded 2026 Outlook And Biologics Momentum
16.06.2026 01:09
West Pharmaceutical Services recently reported strong first-quarter 2026 results, highlighting robust growth in biologics-related high-value components and self-injection delivery devices, and raised its full-year 2026 revenue and adjusted EPS guidance. The company emphasized its role as a critical part of injectable-drug infrastructure rather than a conventional packaging supplier, underlining how its specialized high-value products support complex biologic therapies. Next, we’ll examine...
Hinge Health Expands HingeSelect to Offer End-to-End MSK Surgical Care
11.06.2026 14:19
HNGE expands HingeSelect to include orthopedic surgery, aiming to deliver coordinated end-to-end MSK care from imaging to post-op recovery.